IBDEI02A ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2607,1,4,0)
 ;;=4^440.24
 ;;^UTILITY(U,$J,358.3,2607,1,5,0)
 ;;=5^PVD w/ Gangrene
 ;;^UTILITY(U,$J,358.3,2607,2)
 ;;=PVD w/ Gangrene^295740
 ;;^UTILITY(U,$J,358.3,2608,0)
 ;;=V45.81^^32^201^76
 ;;^UTILITY(U,$J,358.3,2608,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2608,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,2608,1,5,0)
 ;;=5^S/P CABG
 ;;^UTILITY(U,$J,358.3,2608,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,2609,0)
 ;;=459.81^^32^201^86
 ;;^UTILITY(U,$J,358.3,2609,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2609,1,4,0)
 ;;=4^459.81
 ;;^UTILITY(U,$J,358.3,2609,1,5,0)
 ;;=5^Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,2609,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,2610,0)
 ;;=V45.01^^32^201^78
 ;;^UTILITY(U,$J,358.3,2610,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2610,1,4,0)
 ;;=4^V45.01
 ;;^UTILITY(U,$J,358.3,2610,1,5,0)
 ;;=5^S/P Pacer Placement
 ;;^UTILITY(U,$J,358.3,2610,2)
 ;;=^303419
 ;;^UTILITY(U,$J,358.3,2611,0)
 ;;=427.31^^32^201^15
 ;;^UTILITY(U,$J,358.3,2611,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2611,1,4,0)
 ;;=4^427.31
 ;;^UTILITY(U,$J,358.3,2611,1,5,0)
 ;;=5^Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,2611,2)
 ;;=^11378
 ;;^UTILITY(U,$J,358.3,2612,0)
 ;;=427.89^^32^201^17
 ;;^UTILITY(U,$J,358.3,2612,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2612,1,4,0)
 ;;=4^427.89
 ;;^UTILITY(U,$J,358.3,2612,1,5,0)
 ;;=5^Bradycardia
 ;;^UTILITY(U,$J,358.3,2612,2)
 ;;=Bradycardia^87896
 ;;^UTILITY(U,$J,358.3,2613,0)
 ;;=427.9^^32^201^23
 ;;^UTILITY(U,$J,358.3,2613,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2613,1,4,0)
 ;;=4^427.9
 ;;^UTILITY(U,$J,358.3,2613,1,5,0)
 ;;=5^Cardiac Dysrythmia
 ;;^UTILITY(U,$J,358.3,2613,2)
 ;;=^10166
 ;;^UTILITY(U,$J,358.3,2614,0)
 ;;=427.0^^32^201^72
 ;;^UTILITY(U,$J,358.3,2614,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2614,1,4,0)
 ;;=4^427.0
 ;;^UTILITY(U,$J,358.3,2614,1,5,0)
 ;;=5^Paroxysmal Supravent Tachycardia
 ;;^UTILITY(U,$J,358.3,2614,2)
 ;;=^90479
 ;;^UTILITY(U,$J,358.3,2615,0)
 ;;=427.81^^32^201^79
 ;;^UTILITY(U,$J,358.3,2615,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2615,1,4,0)
 ;;=4^427.81
 ;;^UTILITY(U,$J,358.3,2615,1,5,0)
 ;;=5^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,2615,2)
 ;;=^110852
 ;;^UTILITY(U,$J,358.3,2616,0)
 ;;=785.0^^32^201^81
 ;;^UTILITY(U,$J,358.3,2616,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2616,1,4,0)
 ;;=4^785.0
 ;;^UTILITY(U,$J,358.3,2616,1,5,0)
 ;;=5^Tachycardia
 ;;^UTILITY(U,$J,358.3,2616,2)
 ;;=Tachycardia^117041
 ;;^UTILITY(U,$J,358.3,2617,0)
 ;;=785.1^^32^201^71
 ;;^UTILITY(U,$J,358.3,2617,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2617,1,4,0)
 ;;=4^785.1
 ;;^UTILITY(U,$J,358.3,2617,1,5,0)
 ;;=5^Palpitations
 ;;^UTILITY(U,$J,358.3,2617,2)
 ;;=Palpitations^89281
 ;;^UTILITY(U,$J,358.3,2618,0)
 ;;=424.1^^32^201^11
 ;;^UTILITY(U,$J,358.3,2618,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2618,1,4,0)
 ;;=4^424.1
 ;;^UTILITY(U,$J,358.3,2618,1,5,0)
 ;;=5^Aortic Stenosis
 ;;^UTILITY(U,$J,358.3,2618,2)
 ;;=Aortic Stenosis^9330
 ;;^UTILITY(U,$J,358.3,2619,0)
 ;;=424.0^^32^201^63
 ;;^UTILITY(U,$J,358.3,2619,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2619,1,4,0)
 ;;=4^424.0
 ;;^UTILITY(U,$J,358.3,2619,1,5,0)
 ;;=5^Mitral Valve Prolapse
 ;;^UTILITY(U,$J,358.3,2619,2)
 ;;=^78367
 ;;^UTILITY(U,$J,358.3,2620,0)
 ;;=394.0^^32^201^62
 ;;^UTILITY(U,$J,358.3,2620,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2620,1,4,0)
 ;;=4^394.0
 ;;^UTILITY(U,$J,358.3,2620,1,5,0)
 ;;=5^Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,2620,2)
 ;;=Mitral Stenosis^78404
 ;;^UTILITY(U,$J,358.3,2621,0)
 ;;=394.9^^32^201^40
 ;;^UTILITY(U,$J,358.3,2621,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2621,1,4,0)
 ;;=4^394.9
 ;;^UTILITY(U,$J,358.3,2621,1,5,0)
 ;;=5^Heart Dis Mitral Valve
 ;;^UTILITY(U,$J,358.3,2621,2)
 ;;=^269571
 ;;^UTILITY(U,$J,358.3,2622,0)
 ;;=397.1^^32^201^41
 ;;^UTILITY(U,$J,358.3,2622,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2622,1,4,0)
 ;;=4^397.1
 ;;^UTILITY(U,$J,358.3,2622,1,5,0)
 ;;=5^Heart Dis Pulmon Valve
 ;;^UTILITY(U,$J,358.3,2622,2)
 ;;=^269587
 ;;^UTILITY(U,$J,358.3,2623,0)
 ;;=397.0^^32^201^42
 ;;^UTILITY(U,$J,358.3,2623,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2623,1,4,0)
 ;;=4^397.0
 ;;^UTILITY(U,$J,358.3,2623,1,5,0)
 ;;=5^Heart Dis Tricuspid Valve
 ;;^UTILITY(U,$J,358.3,2623,2)
 ;;=^35528
 ;;^UTILITY(U,$J,358.3,2624,0)
 ;;=424.90^^32^201^83
 ;;^UTILITY(U,$J,358.3,2624,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2624,1,4,0)
 ;;=4^424.90
 ;;^UTILITY(U,$J,358.3,2624,1,5,0)
 ;;=5^Valvular Heart Disease
 ;;^UTILITY(U,$J,358.3,2624,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,2625,0)
 ;;=V43.3^^32^201^77
 ;;^UTILITY(U,$J,358.3,2625,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2625,1,4,0)
 ;;=4^V43.3
 ;;^UTILITY(U,$J,358.3,2625,1,5,0)
 ;;=5^S/P Heart Valve Replacement
 ;;^UTILITY(U,$J,358.3,2625,2)
 ;;=^295440
 ;;^UTILITY(U,$J,358.3,2626,0)
 ;;=401.1^^32^201^58
 ;;^UTILITY(U,$J,358.3,2626,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2626,1,4,0)
 ;;=4^401.1
 ;;^UTILITY(U,$J,358.3,2626,1,5,0)
 ;;=5^Hypertension, Benign
 ;;^UTILITY(U,$J,358.3,2626,2)
 ;;=^269591
 ;;^UTILITY(U,$J,358.3,2627,0)
 ;;=796.2^^32^201^32
 ;;^UTILITY(U,$J,358.3,2627,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2627,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,2627,1,5,0)
 ;;=5^Elev BP w/o dx hypertension
 ;;^UTILITY(U,$J,358.3,2627,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,2628,0)
 ;;=402.10^^32^201^33
 ;;^UTILITY(U,$J,358.3,2628,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2628,1,4,0)
 ;;=4^402.10
 ;;^UTILITY(U,$J,358.3,2628,1,5,0)
 ;;=5^HTN w/ Heart Involvement
 ;;^UTILITY(U,$J,358.3,2628,2)
 ;;=^269598
 ;;^UTILITY(U,$J,358.3,2629,0)
 ;;=402.11^^32^201^34
 ;;^UTILITY(U,$J,358.3,2629,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2629,1,4,0)
 ;;=4^402.11
 ;;^UTILITY(U,$J,358.3,2629,1,5,0)
 ;;=5^HTN with CHF
 ;;^UTILITY(U,$J,358.3,2629,2)
 ;;=HTN with CHF^269599
 ;;^UTILITY(U,$J,358.3,2630,0)
 ;;=403.11^^32^201^39
 ;;^UTILITY(U,$J,358.3,2630,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2630,1,4,0)
 ;;=4^403.11
 ;;^UTILITY(U,$J,358.3,2630,1,5,0)
 ;;=5^HTN with Renal Failure
 ;;^UTILITY(U,$J,358.3,2630,2)
 ;;=^269608
 ;;^UTILITY(U,$J,358.3,2631,0)
 ;;=404.10^^32^201^37
 ;;^UTILITY(U,$J,358.3,2631,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2631,1,4,0)
 ;;=4^404.10
 ;;^UTILITY(U,$J,358.3,2631,1,5,0)
 ;;=5^HTN with Heart & Renal Involvement
 ;;^UTILITY(U,$J,358.3,2631,2)
 ;;=^269618
 ;;^UTILITY(U,$J,358.3,2632,0)
 ;;=404.11^^32^201^35
 ;;^UTILITY(U,$J,358.3,2632,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2632,1,4,0)
 ;;=4^404.11
 ;;^UTILITY(U,$J,358.3,2632,1,5,0)
 ;;=5^HTN with CHF & Renal Involvement
 ;;^UTILITY(U,$J,358.3,2632,2)
 ;;=^269619
 ;;^UTILITY(U,$J,358.3,2633,0)
 ;;=404.12^^32^201^38
 ;;^UTILITY(U,$J,358.3,2633,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2633,1,4,0)
 ;;=4^404.12
 ;;^UTILITY(U,$J,358.3,2633,1,5,0)
 ;;=5^HTN with Heart Involvement & Renal Failure
 ;;^UTILITY(U,$J,358.3,2633,2)
 ;;=^269620
 ;;^UTILITY(U,$J,358.3,2634,0)
 ;;=404.13^^32^201^36
 ;;^UTILITY(U,$J,358.3,2634,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2634,1,4,0)
 ;;=4^404.13
 ;;^UTILITY(U,$J,358.3,2634,1,5,0)
 ;;=5^HTN with CHF & Renal failure
 ;;^UTILITY(U,$J,358.3,2634,2)
 ;;=^269621
 ;;^UTILITY(U,$J,358.3,2635,0)
 ;;=401.9^^32^201^59
 ;;^UTILITY(U,$J,358.3,2635,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2635,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,2635,1,5,0)
 ;;=5^Hypertension, Essential
 ;;^UTILITY(U,$J,358.3,2635,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,2636,0)
 ;;=272.0^^32^201^56
 ;;^UTILITY(U,$J,358.3,2636,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2636,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,2636,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,2636,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,2637,0)
 ;;=272.1^^32^201^60
 ;;^UTILITY(U,$J,358.3,2637,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2637,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,2637,1,5,0)
 ;;=5^Hypertriglyceridemia
 ;;^UTILITY(U,$J,358.3,2637,2)
 ;;=Hypertriglyceridemia^101303
 ;;^UTILITY(U,$J,358.3,2638,0)
 ;;=272.2^^32^201^64
 ;;^UTILITY(U,$J,358.3,2638,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2638,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,2638,1,5,0)
 ;;=5^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,2638,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,2639,0)
 ;;=396.0^^32^201^13
 ;;^UTILITY(U,$J,358.3,2639,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2639,1,4,0)
 ;;=4^396.0
 ;;^UTILITY(U,$J,358.3,2639,1,5,0)
 ;;=5^Aortic and Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,2639,2)
 ;;=Aortic and Mitral Stenosis^269580
 ;;^UTILITY(U,$J,358.3,2640,0)
 ;;=414.02^^32^201^19
 ;;^UTILITY(U,$J,358.3,2640,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2640,1,4,0)
 ;;=4^414.02
 ;;^UTILITY(U,$J,358.3,2640,1,5,0)
 ;;=5^CAD, Occlusion of Venous Graft
 ;;^UTILITY(U,$J,358.3,2640,2)
 ;;=CAD, Occlusion of Venous Graft^303282
 ;;^UTILITY(U,$J,358.3,2641,0)
 ;;=459.10^^32^201^75
 ;;^UTILITY(U,$J,358.3,2641,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2641,1,4,0)
 ;;=4^459.10
 ;;^UTILITY(U,$J,358.3,2641,1,5,0)
 ;;=5^Post Phlebotic Syndrome
 ;;^UTILITY(U,$J,358.3,2641,2)
 ;;=Post Phlebotic Syndrome^328597
 ;;^UTILITY(U,$J,358.3,2642,0)
 ;;=428.20^^32^201^52
 ;;^UTILITY(U,$J,358.3,2642,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2642,1,4,0)
 ;;=4^428.20
 ;;^UTILITY(U,$J,358.3,2642,1,5,0)
 ;;=5^Heart Failure, Systolic, Unspec
 ;;^UTILITY(U,$J,358.3,2642,2)
 ;;=Heart Failure, Systolic^328594
 ;;^UTILITY(U,$J,358.3,2643,0)
 ;;=428.21^^32^201^44
 ;;^UTILITY(U,$J,358.3,2643,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2643,1,4,0)
 ;;=4^428.21
 ;;^UTILITY(U,$J,358.3,2643,1,5,0)
 ;;=5^Heart Failure, Acute Systolic
 ;;^UTILITY(U,$J,358.3,2643,2)
 ;;=Heart Failure, Acute Systolic^328494
 ;;^UTILITY(U,$J,358.3,2644,0)
 ;;=428.22^^32^201^46
 ;;^UTILITY(U,$J,358.3,2644,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2644,1,4,0)
 ;;=4^428.22
